In vitro teratogenicity testing using a 3D, embryo-like gastruloid system
Open Access
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Reproductive Toxicology
- Vol. 105, 72-90
Abstract
No abstract availableKeywords
All Related Versions
This publication has 38 references indexed in Scilit:
- Barrier Mechanisms in the Developing BrainFrontiers in Pharmacology, 2012
- The validated embryonic stem cell test to predict embryotoxicity in vitroNature Protocols, 2011
- Differences between the Measured and Calculated Free Serum Phenytoin Concentrations in Epileptic PatientsYonsei Medical Journal, 2009
- Antibiotic Use in Pregnancy and LactationObstetrics & Gynecology, 2006
- Embryotoxicity and Teratogenicity of Topical Retinoic AcidSkin Pharmacology and Physiology, 1993
- Valproic Acid‐Induced Neural Tube Defects in Mouse and Human: Aspects of Chirality, Alternative Drug Development, Pharmacokinetics and Possible MechanismsBasic & Clinical Pharmacology & Toxicology, 1991
- Valproic acidTeratology, 1987
- HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cellsNature, 1987
- Retinoic Acid EmbryopathyNew England Journal of Medicine, 1985
- Absorption, distribution and toxicity of ibuprofenToxicology and Applied Pharmacology, 1969